Ledger.Open graph →
SEC Form D · filed August 1, 2024

Outpace Bio, Inc

Offering
$144.2M
Sold
$56.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Vasudev Bailey · Seattle, WADirectorJake Simson · Cambridge, MADirectorAaron Foster · Seattle, WAExecBahija Jallal · Abingdon, Oxfordshire, United KingdomDirectorCharity Scripture · Seattle, WAExecScott Boyken · Seattle, WAExec · Director · PromoterEric Soller · Seattle, WAExecMarc Lajoie · Seattle, WAExec · Director · PromoterJake Simson · Cambridge, MADirectorAaron Foster · Seattle, WAExecBahija Jallal · Abingdon, Oxfordshire, United KingdomDirectorVasudev Bailey · SANTA CRUZ, CADirectorCharity Scripture · Seattle, WAExecScott Boyken · Seattle, WAExec · Director · PromoterEric Soller · Seattle, WAExecMarc Lajoie · Seattle, WAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗